ONCT
Oncternal Therapeutics Inc
NASDAQ: ONCT · HEALTHCARE · BIOTECHNOLOGY
$0.53
+0.00% today
Updated 2026-04-30
Market cap
$1.56M
P/E ratio
—
P/S ratio
0.72x
EPS (TTM)
$-11.69
Dividend yield
—
52W range
$0 – $0
Volume
—
Oncternal Therapeutics Inc (ONCT) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+4.4%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-1582.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2024-09-30 | $-3.19 | $-2.86 | +10.3% | — | — |
| 2024-06-30 | $-3.10 | $-2.89 | +6.8% | $801000.00 | +655.7% |
| 2024-03-31 | $-2.88 | $-2.83 | +1.7% | $569000.00 | +232.7% |
| 2023-12-31 | $-3.07 | $-3.11 | -1.3% | $297000.00 | +73.7% |
| 2023-09-30 | $-0.14 | $-0.17 | -21.4% | $179000.00 | -53.1% |
| 2023-06-30 | $-0.16 | $-0.15 | +6.3% | $106000.00 | -44.5% |
| 2023-03-31 | $-0.20 | $-0.20 | +0.0% | $171000.00 | -77.1% |
| 2022-12-31 | $-0.21 | $-0.20 | +4.8% | $171000.00 | -69.2% |
| 2022-09-30 | $-0.24 | $-0.21 | +12.5% | $382000.00 | — |
| 2022-06-30 | $-0.23 | $-0.23 | +0.0% | $191000.00 | — |
| 2022-03-31 | $-0.20 | $-0.20 | +0.0% | $746000.00 | — |
| 2021-12-31 | $-0.25 | $-0.16 | +36.0% | $556000.00 | — |
Frequently asked questions
Has Oncternal Therapeutics Inc beaten earnings estimates?
Oncternal Therapeutics Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +4.4% over the last 4 quarters.